Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease.
about
IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infectionInterleukin-10 attenuation of collagen-induced arthritis is associated with suppression of interleukin-17 and retinoid-related orphan receptor γt production in macrophages and repression of classically activated macrophages.A novel murine model of inflammatory bowel disease and inflammation-associated colon cancer with ulcerative colitis-like features.Fungal chitin dampens inflammation through IL-10 induction mediated by NOD2 and TLR9 activation.Regulation of TH17 cell differentiation by innate immune signals.Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammationPolymorphisms of the cytokine genes TGFB1 and IL10 in a mixed-race population with Crohn's disease.Changes of the cytokine profile in inflammatory bowel diseases.Effector and regulatory T cell subsets in diabetes-associated inflammation. Is there a connection with ST2/IL-33 axis? Perspective.Targeting IL-10 in auto-immune diseases.Hidradenitis suppurativa: the role of immune dysregulation.Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor DevelopmentInterleukin-10 gene-carrying bifidobacteria ameliorate murine ulcerative colitis by regulating regulatory T cell/T helper 17 cell pathway.Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease.
P2860
Q27335548-01A2794A-2946-42EC-B05B-50910EA5A545Q33767035-310C0D62-F635-4D98-8173-964B07268D4BQ34359061-2644CAB4-1073-4537-BD9E-41F3E78CBB79Q35145107-A42EF1A3-2D69-46F5-81EF-9740EF8A9B97Q36178278-B8C6052C-B58F-4F2D-A45A-2FCFC850CD42Q37259195-B2E74E6A-DAF0-4654-B52E-7042F21E6C30Q37361269-2C59E052-153A-4B48-B968-D298BEAAE0D5Q38058782-77BEE1C5-9854-4981-B329-6045404A44CAQ38189119-568AD800-21EA-4D83-994F-7D576D23EC84Q38196752-1ADB579D-0FC4-4AE4-ACC8-EE945CD8C894Q38222887-F3D4F9FE-E405-4939-AD0E-9C68C72ADFCDQ41684112-08C1CD41-CB0F-4525-B8B9-19E416A6CF5AQ41763748-7070B563-C009-4033-87EC-D596E8FC9AF9Q53083936-3869983C-677B-4771-8569-9F7E6802CC4A
P2860
Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Endogenous interleukin-10 cons ...... th inflammatory bowel disease.
@ast
Endogenous interleukin-10 cons ...... th inflammatory bowel disease.
@en
type
label
Endogenous interleukin-10 cons ...... th inflammatory bowel disease.
@ast
Endogenous interleukin-10 cons ...... th inflammatory bowel disease.
@en
prefLabel
Endogenous interleukin-10 cons ...... th inflammatory bowel disease.
@ast
Endogenous interleukin-10 cons ...... th inflammatory bowel disease.
@en
P2093
P2860
P356
P1476
Endogenous interleukin-10 cons ...... th inflammatory bowel disease.
@en
P2093
Cailin M Wilke
Ilona Kryczek
Jingyuan Fang
Shuang Wei
Weiping Zou
Yanwei Lin
P2860
P2888
P356
10.1186/1479-5876-9-217
P577
2011-12-16T00:00:00Z
P5875
P6179
1038142490